Search Results 1871-1880 of 17250 for magnesiummagnesium

1. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   ... mg/day or equivalent. Current alcohol or substance abuse in the opinion of the investigator. Pregnant, breastfeeding, or planning to become pregnant or ...

2. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

   Serum total bilirubin < 2 mg/dL, unless resulting from hemolysis or known Gilbert's disease. AST/ALT < 2.5 x institutional ULN. Adequate renal function ...

3. Health Topics - Mayo Clinic News Network

   ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest radiation oncology findings at the 2025 American Society for ...

4. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

   (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study ...

5. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Systematic treatment with, or any condition requiring, either corticosteroids (>10 mg daily prednisone equivalent) or other immunosuppressive medications ...

6. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors - Mayo Clinic

   - Systemic steroid therapy (>10 mg/day of prednisone or equivalent) or any immune suppressive therapy - Persisting toxicity of ≥Grade 2 (≥Grade 1 for ...

7. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

   ... mg daily) are also eligible; No ongoing cardiac dysrhythmias, atrial fibrillation, or prolongation of corrected QT (QTc) interval to > 480 msec; No evidence ...

8. Vaginal bleeding - Mayo Clinic

   This is called the menstrual cycle. The blood comes from the lining of the uterus, which is shed through the vagina. When this happens, a new reproductive cycle ...

9. A Study to Evaluate Firstline Pembrolizumab Alone or in Combination with Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients with Stage IV Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 mg/dL (obtained within 14 days of randomization). Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) ...

10. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

    Continuous systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 2 weeks prior ...